Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Motor Activity 54Breast Neoplasms 30Neoplasms 24Lung Neoplasms 8Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Colonic Neoplasms 6Polycystic Ovary Syndrome 5Pancreatic Neoplasms 5Ovarian Neoplasms 5Obesity 5Fatigue 5Prostatic Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Lymphoma 4Lymphedema 4Esophageal Neoplasms 4Brain Neoplasms 4Stomach Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Peripheral Nervous System Diseases 3Hematologic Neoplasms 3Endometrial Neoplasms 3Skin Neoplasms 2Sarcopenia 2Recurrence 2Rectal Neoplasms 2Neoplasm Metastasis 2Melanoma 2

Interventions

Cyclophosphamide 49fludarabine 36Dexamethasone 35venetoclax 29pembrolizumab 26Rituximab 21Lenalidomide 18pomalidomide 17Gemcitabine 17fludarabine phosphate 15Etoposide 14Cytarabine 13daratumumab 11carfilzomib 11Temozolomide 11Cisplatin 10Calcium Dobesilate 10glofitamab 9Nivolumab 9Injections 9Azacitidine 9selinexor 8Vincristine 8Carboplatin 8Bortezomib 8obinutuzumab 7Immunotherapy, Adoptive 7Bevacizumab 7zanubrutinib 6ruxolitinib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Exercise × 1 year × Clear all
NCT07030686 2026-04-28

Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors

Memorial Sloan Kettering Cancer Center

Recruiting
1,000 enrolled

Motor Activity, Neoplasms, Recurrence

NCT03525873 2026-04-15

A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy

M.D. Anderson Cancer Center

Phase 3 Active not recruiting
212 enrolled

Neoplasm Metastasis, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡